Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.23 USD
+0.01 (0.82%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $1.23 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 18.92% |
ABR | 2.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -0.87 |
EPS (TTM) | -1.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.99M | 2.01M | 7.55M | 9.00M |
# of Estimates | 5 | 5 | 6 | 5 |
High Estimate | 5.30M | 5.30M | 21.40M | 23.50M |
Low Estimate | 0.57M | 0.57M | 2.26M | 2.26M |
Year ago Sales | 2.53M | 1.87M | 31.25M | 7.55M |
Year over Year Growth Est. | -21.42% | 7.38% | -75.83% | 19.20% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.23 | -0.98 | -0.87 |
# of Estimates | 5 | 5 | 7 | 5 |
Most Recent Consensus | -0.31 | -0.23 | -1.00 | -0.62 |
High Estimate | -0.08 | -0.08 | -0.32 | -0.31 |
Low Estimate | -0.35 | -0.34 | -1.35 | -1.49 |
Year ago EPS | -0.42 | -0.42 | -1.55 | -0.98 |
Year over Year Growth Est. | 33.33% | 45.24% | 36.77% | 11.52% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.23 | -0.98 | -0.87 |
7 Days Ago | -0.28 | -0.23 | -0.98 | -0.87 |
30 Days Ago | -0.28 | -0.23 | -0.98 | -0.87 |
60 Days Ago | -0.33 | -0.28 | -1.05 | -1.07 |
90 Days Ago | -0.34 | -0.29 | -1.12 | -1.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.23 | -0.98 | -0.87 |
Zacks Consensus Estimate | -0.28 | -0.23 | -0.98 | -0.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.41 | -0.42 | -0.42 | NA |
Estimate | -0.37 | -0.48 | -0.45 | -0.44 | NA |
Difference | 0.07 | 0.07 | 0.03 | 0.02 | 0.05 |
Surprise | 18.92% | 14.58% | 6.67% | 4.55% | 11.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more